Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T76414 | ||||
Target Name | Glutamate NMDA receptor subunit epsilon 2 | ||||
Synonyms | Glutamate receptor NR2B subunit; HNR3; N-methyl-D-aspartate receptor subunit 3; N-methylD-aspartate receptor subtype 2B; NMDA NR2B receptor; NMDA receptor NR2B; NMDA receptor subunit 2B; NMDAR2B; NR2B; NR3; GRIN2B | ||||
Target Type | Clinical Trial | ||||
Gene Name | GRIN2B | ||||
Biochemical Class | Glutamate-gated ion channel | ||||
UniProt ID | NMDE2_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Depression | ||||
Example drug | CERC-301 | Phase 2 | [525218], [1572592] | ||
Tissue | Pre-frontal cortex | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: 0.14 Z-score: 0.29 P-value: 1.23E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Disease | Multiple sclerosis | ||||
Example drug | ELIPRODIL | Phase 2 | [521427], [1572592] | ||
Tissue | Spinal cord | ||||
Level of differential expression between the patients in the disease section of the tissue and the patients in the normal section of the tissue adjacent to the disease section | Fold-change: 0.01 Z-score: 0.27 P-value: 6.76E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles of the patients in the normal section of the tissue adjacent to the disease section
|
|||||
Disease | Parkinson's disease | ||||
Example drug | CP-101,606 | Phase 2 | [521577], [1572592] | ||
Tissue | Substantia nigra tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.06 Z-score: -0.32 P-value: 7.51E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
Reference | |||||
Ref 521427 | ClinicalTrials.gov (NCT00001929) Treatment of Parkinson's Disease With Eliprodil. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.